NFKB1 and rheumatoid arthritis: Correspondingly, it was demonstrated that IL-38 showed suppressive impacts on LPS-mediated TLR4 secretion, leading to an attenuated inflammation in patients with RA through inhibition of the activation of NF-κB [120].